Gö6983 attenuates breast cancer‐induced osteolysis by the apoptotic pathway
0301 basic medicine
0303 health sciences
Indoles
Macrophages
Mice, Nude
Osteoclasts
Apoptosis
Bone Neoplasms
Breast Neoplasms
Cell Differentiation
Osteolysis
Mitochondria
3. Good health
Maleimides
Mice, Inbred C57BL
Mice
03 medical and health sciences
Cell Line, Tumor
Animals
Protein Kinase Inhibitors
DOI:
10.1002/cbin.11281
Publication Date:
2019-12-09T05:52:25Z
AUTHORS (11)
ABSTRACT
AbstractBone metastasis caused by breast cancer leads to significant complications in treatment, and the resulting osteolysis considerably affects patients’ overall survival and quality of life. Gö6983 is a broad spectrum protein kinase C inhibitor. In this study, based on our finding that the Gö6983 inhibits osteolysis, we applied Gö6983 to the MDA‐MB‐231 breast cancer‐induced mouse bone metastasis model. And we found that Gö6983 has a strong inhibitory effect on the tumorigenic model of breast cancer by promoting the mitochondrial apoptosis pathway. Our study, therefore, demonstrates that Gö6983 has a potential inhibitory effect on breast cancer‐induced osteoclast activation and provides mechanistic insight that may prove useful for designing future treatments.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....